The role of CXC chemokines and their receptors in the progression and treatment of tumors (Q38023245)

27 August 2017

title

The role of CXC chemokines and their receptors in the progression and treatment of tumors (English)

1 reference

27 August 2017

Qingchao Zhu

1

1 reference

27 August 2017

Xiaodong Han

2

1 reference

27 August 2017

Jiayuan Peng

3

1 reference

27 August 2017

Huanlong Qin

4

1 reference

27 August 2017

Yu Wang

5

1 reference

27 August 2017

language of work or name

1 reference

30 June 2012

1 reference

Journal of Molecular Histology

27 August 2017

published in

1 reference

27 August 2017

volume

43

1 reference

27 August 2017

issue

6

1 reference

27 August 2017

page(s)

699-713

1 reference

The CXC chemokine receptor 2, CXCR2, is the putative receptor for ELR CXC chemokine-induced angiogenic activity

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007/S10735-012-9435-X

The CXC chemokine, monokine induced by interferon-gamma, inhibits non-small cell lung carcinoma tumor growth and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10735-012-9435-X

Overexpression of the duffy antigen receptor for chemokines (DARC) by NSCLC tumor cells results in increased tumor necrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10735-012-9435-X

Widespread Hypomethylation Occurs Early and Synergizes with Gene Amplification during Esophageal Carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10735-012-9435-X

Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10735-012-9435-X

Interferon-gamma-inducible protein 10 (IP-10) is an angiostatic factor that inhibits human non-small cell lung cancer (NSCLC) tumorigenesis and spontaneous metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10735-012-9435-X

Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10735-012-9435-X

Chemokines: key players in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10735-012-9435-X

Clinical importance and therapeutic implications of the pivotal CXCL12-CXCR4 (chemokine ligand-receptor) interaction in cancer cell migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10735-012-9435-X

CXCL14 is an autocrine growth factor for fibroblasts and acts as a multi-modal stimulator of prostate tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10735-012-9435-X

Regulation of vascular development by fibroblast growth factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10735-012-9435-X

Epigenetics underpinning the regulation of the CXC (ELR ) chemokines in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10735-012-9435-X

Cancer and the chemokine network

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10735-012-9435-X

The significance of cancer cell expression of the chemokine receptor CXCR4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10735-012-9435-X

Platelet factor 4: an inhibitor of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10735-012-9435-X

The control of angiogenesis and tumor invasion by platelet factor-4 and platelet factor-4-derived molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10735-012-9435-X

Characterization of the role of melanoma growth stimulatory activity (MGSA) in the growth of normal melanocytes, nevocytes, and malignant melanocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10735-012-9435-X

CXCR4 and CXCL12 are inversely expressed in colorectal cancer cells and modulate cancer cell migration, invasion and MMP-9 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10735-012-9435-X

Regulation of CXCL8/IL-8 expression by zonula occludens-1 in human breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10735-012-9435-X

A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10735-012-9435-X

CXCR3 ligands are augmented during the pathogenesis of pulmonary sarcoidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10735-012-9435-X

The role of CXC chemokines in the regulation of tumor angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10735-012-9435-X

Identification and partial characterization of a variant of human CXCR3 generated by posttranscriptional exon skipping

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10735-012-9435-X

Angiogenesis and Prostate Cancer: In vivo and In vitro Expression of Angiogenesis Factors by Prostate Cancer Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10735-012-9435-X

Direct inhibition of human acute myeloid leukemia cell growth by IL-12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10735-012-9435-X

In vivo expression of the novel CXC chemokine BRAK in normal and cancerous human tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10735-012-9435-X

Inhibition of endothelial cell proliferation by platelet factor-4 involves a unique action on S phase progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10735-012-9435-X

EBV-induced molecule 1 ligand chemokine (ELC/CCL19) promotes IFN-gamma-dependent antitumor responses in a lung cancer model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10735-012-9435-X

Chemokines: agents for the immunotherapy of cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10735-012-9435-X

Chemokine/chemokine receptor nomenclature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10735-012-9435-X

Pivotal role of CXCR3 in melanoma cell metastasis to lymph nodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10735-012-9435-X

Depletion of CXCR2 inhibits tumor growth and angiogenesis in a murine model of lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10735-012-9435-X

Chemokines as mediators of neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10735-012-9435-X

CXC chemokines in cancer angiogenesis and metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10735-012-9435-X

Chemokines as mediators of tumor angiogenesis and neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10735-012-9435-X

The SDF-1-CXCR4 axis stimulates VEGF secretion and activates integrins but does not affect proliferation and survival in lymphohematopoietic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10735-012-9435-X

The chemokine network in acute myelogenous leukemia: molecular mechanisms involved in leukemogenesis and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10735-012-9435-X

The chemokine network in cancer--much more than directing cell movement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10735-012-9435-X

An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10735-012-9435-X

Intratumoral coinjection of two adenoviral vectors expressing functional interleukin-18 and inducible protein-10, respectively, synergizes to facilitate regression of established tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10735-012-9435-X

Chemokines — Chemotactic Cytokines That Mediate Inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10735-012-9435-X

CXCR3 expression is associated with poor survival in breast cancer and promotes metastasis in a murine model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10735-012-9435-X

Inhibition of Angiogenesis by Recombinant Human Platelet Factor-4 and Related Peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10735-012-9435-X

Interleukin-8 induces nuclear transcription factor-kappaB through a TRAF6-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10735-012-9435-X

Epidermal growth factor receptor targeting in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10735-012-9435-X

CXC chemokines mechanism of action in regulating tumor angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10735-012-9435-X

Distinct CXC chemokines mediate tumorigenicity of prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10735-012-9435-X

Involvement of chemokine receptors in breast cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10735-012-9435-X

Review: The chemokine receptor CXCR3 and its ligands CXCL9, CXCL10 and CXCL11 in neuroimmunity--a tale of conflict and conundrum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10735-012-9435-X

Intratumoral coinjection of two adenoviruses, one encoding the chemokine IFN-gamma-inducible protein-10 and another encoding IL-12, results in marked antitumoral synergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10735-012-9435-X

Combined CXC chemokine and interleukin-12 gene transfer enhances antitumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10735-012-9435-X

CXCR6 and CCR5 localize T lymphocyte subsets in nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10735-012-9435-X

Signaling Through Scaffold, Anchoring, and Adaptor Proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10735-012-9435-X

The stromal derived factor-1/CXCL12-CXC chemokine receptor 4 biological axis in non-small cell lung cancer metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10735-012-9435-X

Inflammatory chemokines in cancer growth and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10735-012-9435-X

Cell cycle-dependent expression of CXC chemokine receptor 3 by endothelial cells mediates angiostatic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10735-012-9435-X

The biology of chemokines and their receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10735-012-9435-X

A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10735-012-9435-X

Role of chemokines in angiogenesis: CXCL12/SDF-1 and CXCR4 interaction, a key regulator of endothelial cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10735-012-9435-X

Vascular endothelial growth factor and basic fibroblast growth factor induce expression of CXCR4 on human endothelial cells: In vivo neovascularization induced by stromal-derived factor-1alpha.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10735-012-9435-X

Human neutrophils promote angiogenesis by a paracrine feedforward mechanism involving endothelial interleukin-8.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10735-012-9435-X

Modulation of CXCL14 (BRAK) expression in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10735-012-9435-X

SLC/CCL21-mediated anti-tumor responses require IFNgamma, MIG/CXCL9 and IP-10/CXCL10

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10735-012-9435-X

BRAK/CXCL14 is a potent inhibitor of angiogenesis and a chemotactic factor for immature dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10735-012-9435-X

Interleukin-8 receptors R1 and R2 activate mitogen-activated protein kinases and induce c-fos, independent of Ras and Raf-1 in Chinese hamster ovary cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10735-012-9435-X

CXCR1 and CXCR2 silencing modulates CXCL8-dependent endothelial cell proliferation, migration and capillary-like structure formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10735-012-9435-X

The CC chemokine 6Ckine binds the CXC chemokine receptor CXCR3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10735-012-9435-X

CCL2 regulates angiogenesis via activation of Ets-1 transcription factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10735-012-9435-X

Chemokine-chemokine receptors in cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10735-012-9435-X

The Functional Role of the ELR Motif in CXC Chemokine-mediated Angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10735-012-9435-X

CXC chemokines: angiogenesis, immunoangiostasis, and metastases in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10735-012-9435-X

Cancer CXC chemokine networks and tumour angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10735-012-9435-X

Platelet factor-4 variant chemokine CXCL4L1 inhibits melanoma and lung carcinoma growth and metastasis by preventing angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10735-012-9435-X

Platelets release CXCL4L1, a nonallelic variant of the chemokine platelet factor-4/CXCL4 and potent inhibitor of angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10735-012-9435-X

Regulation of the ERK Subgroup of MAP Kinase Cascades Through G Protein-Coupled Receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10735-012-9435-X

Autocrine growth effect of IL-8 and GROalpha on a human pancreatic cancer cell line, Capan-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10735-012-9435-X

Chemokines in tumor progression and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10735-012-9435-X

The role of CXC chemokines and their receptors in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10735-012-9435-X

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10735-012-9435-X

Regulation of the trafficking of tumour-infiltrating dendritic cells by chemokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10735-012-9435-X

The pivotal role of CXCL12 (SDF-1)/CXCR4 axis in bone metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10735-012-9435-X

The angiostatic activity of interferon-inducible protein-10/CXCL10 in human melanoma depends on binding to CXCR3 but not to glycosaminoglycan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10735-012-9435-X

CXCR4 is a major chemokine receptor on glioma cells and mediates their survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10735-012-9435-X

CXCL10 promotes invasion-related properties in human colorectal carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10735-012-9435-X

Chemokines in neoplastic progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10735-012-9435-X

Chemokines: a new classification system and their role in immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10735-012-9435-X

Differential expression and responsiveness of chemokine receptors (CXCR1-3) by human microvascular endothelial cells and umbilical vein endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10735-012-9435-X

Lymphocyte-specific chemokine receptor CXCR3: regulation, chemokine binding and gene localization

21 January 2018

1 reference

12 December 2020

Mechanism and biological significance of constitutive expression of MGSA/GRO chemokines in malignant melanoma tumor progression

1 reference

12 December 2020

CXCR3 and its binding chemokines in myeloma cells: expression of isoforms and potential relationships with myeloma cell proliferation and survival

1 reference

12 December 2020

Metastatic and non-metastatic colorectal cancer (CRC) cells induce host metalloproteinase production in vivo

1 reference

12 December 2020

CXCR4 neutralization, a novel therapeutic approach for non-Hodgkin's lymphoma

1 reference

12 December 2020

Chemokines as mediators of angiogenesis.

1 reference

12 December 2020

Up-Regulation of Bcl-2 in microvascular endothelial cells enhances intratumoral angiogenesis and accelerates tumor growth

1 reference

12 December 2020

Expression and growth-promoting function of the IL-8 receptor beta in human melanoma cells

1 reference

12 December 2020

Expression of Angiogenesis-Related Genes and Progression of Human Ovarian Carcinomas in Nude Mice

1 reference

12 December 2020

Clinical significance of CXCL16/CXCR6 expression in patients with prostate cancer.

1 reference

12 December 2020

Mig, the monokine induced by interferon-gamma, promotes tumor necrosis in vivo

1 reference

12 December 2020

Interleukin 8 expression regulates tumorigenicity and metastases in androgen-independent prostate cancer.

1 reference

12 December 2020

CXC chemokines in angiogenesis.

1 reference

12 December 2020

Chemokines induce migrational responses in human breast carcinoma cell lines

1 reference

12 December 2020

Expression of interleukin 8 correlates with the metastatic potential of human melanoma cells in nude mice

1 reference

12 December 2020

Coexpression of interleukin-8 receptors in head and neck squamous cell carcinoma

1 reference

12 December 2020

How do chemokine/chemokine receptor activations affect tumorigenesis?

1 reference

12 December 2020

Redirecting in vivo elicited tumor infiltrating macrophages and dendritic cells towards tumor rejection.

1 reference

12 December 2020

Reversible inhibition of IL-8 receptor B mRNA expression and proliferation in non-small cell lung cancer by antisense oligonucleotides

1 reference

12 December 2020

The role of CXC chemokines in the regulation of angiogenesis in non-small cell lung cancer

1 reference

12 December 2020

Vascular endothelial growth factor promotes breast carcinoma invasion in an autocrine manner by regulating the chemokine receptor CXCR4.

1 reference

12 December 2020

MIG (CXCL9) chemokine gene therapy combines with antibody-cytokine fusion protein to suppress growth and dissemination of murine colon carcinoma.

1 reference

12 December 2020

Insights into the viral G protein-coupled receptor encoded by human herpesvirus type 8 (HHV-8).

1 reference

12 December 2020

Platelet factor 4 modulates fibroblast growth factor 2 (FGF-2) activity and inhibits FGF-2 dimerization

1 reference

12 December 2020

CXCL13 activation of c-Myc induces RANK ligand expression in stromal/preosteoblast cells in the oral squamous cell carcinoma tumor-bone microenvironment

1 reference

12 December 2020

Angiogenic effects of interleukin 8 (CXCL8) in human intestinal microvascular endothelial cells are mediated by CXCR2

1 reference

12 December 2020

Purification of melanoma growth stimulatory activity

1 reference

12 December 2020

10.1007/S10735-012-9435-X

Identifiers

DOI

1 reference

27 August 2017

1 reference